Company
editasmedicine.com
Also known as Editas Medicine, Inc
- Business model
- B2B
- Legal name
- Editas Medicine, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Funding snapshot
- Total raised
- $120MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $120M2015-08-04
Funding rounds
- Round, 2015
- $120M2015-08-04, SEC form D sold, 43 investors
Loading relationship preview